Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of November 2025, with a report date of November 10, 2025. The filing primarily addresses a significant change in management and the company's strategic positioning for commercial growth.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure rather than a financial results statement.
Material Changes
- Executive Promotion: On November 5, 2025, the Board of Directors promoted Mr. Shay Levav from Vice President of Regulatory and Quality Assurance and Clinical Applications to Chief Operating Officer (COO).
- Background: Mr. Levav has been with the company since September 2020. Prior to joining Icecure, he held roles at Applied Spectral Imaging and Carestream Health Inc., spanning over two decades in quality, regulatory, and operations management.
Outlook and Management Commentary
On November 10, 2025, the company issued a press release titled "IceCure Promotes Shay Levav to Chief Operating Officer as Company Ramps up for Increased Commercial Traction." This promotion signals management's intent to accelerate commercial activities. The press release is incorporated by reference into the company's active registration statements on Forms F-3 and S-8.
Key Facts for Investor Verification
- Confirm the effective date of Mr. Levav's new role as COO (November 5, 2025).
- Review the full text of the press release (Exhibit 99.1) for specific details on the "ramp up" strategy for commercial traction.
- Verify the incorporation of this press release into the company's outstanding shelf registration statements.